BWXT Awarded $28 Million Contract for Continued Mobile Microreactor Design
(LYNCHBURG, Va. – March 25, 2021) – BWX Technologies, Inc. (NYSE: BWXT) today announced a $28 million, 12-month contract award from the Department of Defense’s (DoD) Strategic Capabilities Office (SCO) for the final design of a transportable microreactor prototype under the second phase of its Project Pele initiative.
BWXT Renames Laker Energy Products to BWXT Precision Manufacturing
(OAKVILLE, ON – March 16, 2021) – BWXT Canada Ltd. announced today that it has renamed its subsidiary Laker Energy Products Ltd. to BWXT Precision Manufacturing Inc.
BWXT Names Jim J. Bittner Vice President and General Manager of Lynchburg, Virginia operations
(LYNCHBURG, Va. – March 15, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that Jim J. Bittner has been named Vice President and General Manager of the BWXT Nuclear Operations Group, Inc. (BWXT NOG) manufacturing facility in Lynchburg, Virginia.
BWXT Awarded $35 Million in Uranium Processing and Research Reactor Fuel Contracts
(LYNCHBURG, Va. – March 11, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Nuclear Operations Group, Inc. (BWXT NOG) subsidiary has been awarded a total of $35 million in contracts under two separate programs – uranium recovery and conversion as well as construction of a new research reactor fuel line.
BWXT and GMS Form Joint Venture in Nuclear Medicine Manufacturing and Distribution in the Asia-Pacific Region
(LYNCHBURG, Va. – March 8, 2021) – BWXT Medical Ltd. (BWXT Medical) and Global Medical Solutions, Ltd. (GMS) have entered into a joint venture (JV) to manufacture and distribute radioisotopes and radiopharmaceuticals in the Asia-Pacific (Asia).
BWXT Subsidiary Awarded $57.5 Million Contract to Prepare for Uranium Conversion and Purification Services
(LYNCHBURG, Va. – March 1, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its Nuclear Fuel Services, Inc. (NFS) subsidiary has received a $57.5 million contract from the National Nuclear Security Administration (NNSA) to prepare for future highly enriched uranium (HEU) conversion and purification services.
BWXT to Present at J.P. Morgan Global High Yield & Leveraged Finance Conference
LYNCHBURG, Va.--(BUSINESS WIRE)-- BWX Technologies, Inc. (NYSE: BWXT) announced today that Chief Financial Officer David Black will be presenting at the virtual J.P. Morgan 2021 Global High Yield & Leveraged Finance Conference on Monday, March 1, 2021.
BWX Technologies Reports Solid Fourth Quarter 2020 Results, Marking New Annual Records for Revenue and Earnings and Achieves Long-Term Guidance
Lynchburg, VA - Feb. 22, 2021 - BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported record revenue in the fourth quarter 2020 at $557 million, an 11% increase compared with $501 million in the fourth quarter 2019. GAAP net income for the fourth quarter 2020 was $65.7 million, or $0.69 per diluted share, compared with GAAP net income of $61.4 million, or $0.64 per diluted share, in the prior-year period. Non-GAAP net income for the fourth quarter 2020 was $70.9 million, or $0.74 per diluted share, compared with non-GAAP net income of $67.9 million, or $0.71 per diluted share, in the prior-year period.
BWXT Names Nuclear Medicine Business as BWXT Medical
(LYNCHBURG, Va. – Feb. 1, 2021) – BWX Technologies, Inc. (NYSE: BWXT) today announced that its subsidiary BWXT ITG Canada, Inc., a nuclear medicine company, has been renamed BWXT Medical Ltd. (BWXT Medical), in order to better align with the company’s products, customer base and strategy.
BWXT Names Rob Smith President of Government Operations
LYNCHBURG, Va.--(BUSINESS WIRE)-- BWX Technologies, Inc. (NYSE: BWXT) announced today Dr. Robert (Rob) F. Smith has been named to the newly created position of president of government operations, reporting to Rex Geveden, BWXT’s president and chief executive officer.